Abbott glucose meter
This article was originally published in The Gray Sheet
Executive Summary
Firm has received new reports of instances wherein its FreeStyle and FreeStyle Flash blood glucose meters in the U.S. "become inoperable or may revert to a reset condition," potentially leading to a change in the units of measurement and, consequently, misguiding therapy decisions. The July 20 announcement follows a related Class I recall in October 2005. Abbott has issued a letter to healthcare professionals and all customers potentially affected. Meanwhile, it reminds users to check each time they test to make sure the meter's display is correct. J&J/LifeScan has had similar issues with its OneTouch Ultra blood glucose meter (1"The Gray Sheet" Jan. 2, 2006, p. 5)...You may also be interested in...
FDA Warning Letter Cites J&J Unit For Not Heeding “User Error” Complaints
Johnson & Johnson/LifeScan received a warning letter for neglecting to adequately follow up on frequent reports of user errors associated with its blood glucose meters
‘Supplement’ On CBD Product Label A Bullseye For US Litigants, Says Attorney
Two CBD marketers warned by FDA in a recent crackdown are targeted in class action complaints alleging they made unsubstantiated health claims and mislabeled ‘illegal drug’ products as supplements. Complaints are a wake-up call to CBD wellness industry to ensure claims are substantiated, as the class action bar is on the prowl following the agency’s 15 warning letter blast in November.
HBW Market News: GNC US Chief, Clasado Commercial Head, Barentz Funding
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: